Pelvic floor
Adjunct care
Claims
Women’s Health Clinic FAQ
How does combining pelvic floor electromagnetic chair therapy (HIFEM) with a G-Shot impact filler displacement risk?
Pelvic-floor physiotherapy or chair-based muscle stimulation should be treated as separate assessment-led care, not as a promise of better G-Shot results.
Direct answer
This page should avoid claiming a predictable displacement effect and explain that pelvic-floor device timing around filler should be reviewed by the clinician. For patients, pelvic-floor treatment may help support, leakage or muscle symptoms, but it should not be presented as a way to promise G-Shot results or sexual satisfaction. A clinician should assess the symptoms, tissue context and goals before deciding whether any procedure is appropriate, especially when previous treatment, discomfort or expectation mismatch may change the safest plan.
This page keeps a technical treatment question patient-facing, cautious and focused on assessment rather than procedure design.
Educational only. Use this as general education before discussing suitability, timing or symptoms with a clinician. Results vary. Not a cure.
G-Shot review
At a glance
These points frame the question before assuming a combined or repeat treatment is suitable.
Key clinical context
A quick, patient-safe summary before treatment suitability is discussed.
Muscle function matters
Tone, weakness, pain and coordination can influence pressure, comfort and leakage.
Adjuncts are separate
Pelvic-floor treatments have their own aims and evidence limits.
Displacement claims need caution
Movement risk cannot be reduced to a public rule about chair therapy.
Outcomes vary
Sexual satisfaction, comfort and leakage may each need different assessment.
Important safety note
Seek medical advice promptly for severe or worsening pelvic or vulval pain, heavy or persistent bleeding, fever, offensive discharge, urinary retention, spreading swelling, tissue colour change, allergic symptoms, fainting or feeling very unwell.
HIFEM
Physio
Support
Review
Detailed answer
Detailed answer
The clinically useful answer explains why this question matters without turning the page into a treatment timetable or protocol.
Clinical bottom line
The decision should be based on symptoms, tissue context, realistic goals and clinician review rather than a public procedural formula.
Safety
Consent
Review
Define the purpose
Pelvic-floor symptoms can overlap with questions about sensation, support, pain, urinary leakage and vaginal pressure.
Respect evidence limits
Physiotherapy or HIFEM-style chair treatment should not be marketed as a way to secure filler position or promise sexual outcomes.
Protect expectations
If symptoms suggest pelvic-floor weakness, overactivity, prolapse, pain or urinary problems, those issues may need assessment before any filler decision.
Keep it clinician-led
A patient-facing answer should separate supportive pelvic-floor care from elective augmentation claims.
What this means in practice
The right plan depends on symptoms, tissue health, previous procedures, healing, consent quality and whether a non-procedural route is more appropriate.
Public information can support good questions, but it should not publish injection, machine-parameter, dissolving, sequencing or re-treatment instructions.
Patient safety
Why this matters
These questions can sound technical, but the real issue is safe decision-making and realistic consent.
It protects consent
Combined or repeat treatments need clear reasons, risks and alternatives.
It protects tissue
Filler, energy, hormone and pelvic-floor factors can interact through healing, pressure, swelling and symptoms.
It protects expectations
Sexual response, satisfaction and filler longevity cannot be promised from treatment stacking.
It protects safety
Pain, urinary symptoms, infection signs and tissue change need clear review thresholds.
The safer interpretation
A conservative plan may involve staging, review, deferral or treating another contributing factor first.
This protects patients from over-treatment, unrealistic sexual claims and avoidable complication risk.
Considerations
What a consultation should consider
Consider the treatment goal, tissue quality, menopause or oestrogen context, pain, urinary symptoms, previous procedures, healing, expectations and whether another route should come first.
What changes the decision
Pain, infection symptoms, urinary problems, GSM, previous procedures, healing concerns, distress, surgery plans or unclear goals can all shift the safest next step.
HIFEM
Physio
Support
The main goal
The consultation reviews leakage, urgency, pelvic pressure, pain, childbirth history, prolapse symptoms, muscle overactivity and previous pelvic-floor care.
Suitability
The clinician considers whether pelvic-floor physiotherapy, urinary assessment or prolapse review should come before or instead of filler.
Consent
If G-Shot treatment is still discussed, consent should avoid promising improved stability, displacement prevention or satisfaction outcomes.
Follow-up
Follow-up should review comfort, urinary symptoms, pressure, pain and whether pelvic-floor referral remains useful.
Practical expectations
A staged or delayed plan can sometimes be safer than adding another intervention quickly.
Exact procedural details, machine parameters, medicines, dissolving decisions and timing changes should be confirmed with the treating clinician.
Common concerns and myths
Common misconceptions
These myths can make combined or repeat intimate treatment sound more predictable than it is.
Myth: pelvic-floor treatment makes filler stay in place
Reality: filler behaviour and muscle function are separate clinical questions.
Myth: chair therapy plus G-Shot promises satisfaction
Reality: satisfaction is influenced by pain, arousal, relationship context, lubrication and expectations.
Myth: leakage means G-Shot is the answer
Reality: urinary symptoms need their own assessment and care plan.
Symptoms and goals
A symptom pattern can guide assessment, but it does not prove that filler, energy treatment or repeat treatment is the answer.
Public information limits
Public education should support safer decisions without teaching intimate procedures, machine parameters or re-treatment routes.
Safety checklist
Safety checklist
Use these checks before assuming another procedure is the next step.
Is the goal clear?
Clarify whether the aim is sensation, comfort, tissue quality, pelvic-floor support, maintenance, imaging review or repeat treatment.
Has sequencing been reviewed?
Combination or repeat treatment should be staged around healing, symptoms and clinical findings.
Are red flags absent?
Pause and seek clinical review for new bleeding, fever, offensive discharge, severe or worsening pain, urinary symptoms, spreading swelling, tissue colour change, allergic symptoms, persistent lumps, pressure or uncertainty about infection.
Is uncertainty documented?
Consent should explain limited evidence, variable response and possible swelling, bruising, discomfort, urinary symptoms or non-response.
Reassuring signs
Symptoms are more reassuring when mild, stable, improving and not associated with fever, colour change, retention, severe pain or systemic illness.
HIFEM
Physio
Reasons to pause
Pause and seek clinical review for new bleeding, fever, offensive discharge, severe or worsening pain, urinary symptoms, spreading swelling, tissue colour change, allergic symptoms, persistent lumps, pressure or uncertainty about infection.
Urinary
Infection
When to escalate
When to seek medical help
Some symptoms after intimate filler or related treatment need urgent assessment rather than routine follow-up.
Use NHS 111 online
Severe or spreading symptoms
Severe pain, spreading swelling, mottling, blanching, tissue colour change or heavy bleeding should be assessed urgently.
Infection symptoms
Fever, offensive discharge, worsening burning, ulcers, pelvic pain or feeling very unwell may need prompt medical review.
Urinary or allergic symptoms
Inability to pass urine, weak stream, breathing difficulty, facial or throat swelling, widespread rash or collapse needs urgent help.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why pelvic-floor assessment can change the plan
Weakness, overactivity, pain or prolapse symptoms can make a filler-first approach less appropriate or less helpful.Why outcome claims should be modest
Support, leakage, sexual comfort and arousal are related but different outcomes. Combining treatments does not make them predictable.Regulatory resources
Authoritative resources
These resources support pelvic-floor assessment, urinary symptom context and careful consent.
NICE urinary incontinence and pelvic organ prolapse guideline
UK guideline supporting urinary and pelvic-floor assessment.
NHS pelvic organ prolapse
UK patient guidance on prolapse symptoms and assessment.
GMC decision making and consent
UK professional guidance for consent and realistic expectation setting.
Next step
Book an intimate health consultation
A consultation can clarify whether symptoms fit tissue health, pelvic-floor concerns, GSM, filler-related questions, combination treatment planning, maintenance review or another cause.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 161 curated sources. Additional reviewed material included peer-reviewed clinical papers; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
